A big alert to users of the WHOOP wearable, Geeks: The FDA just issued a Warning Letter to WHOOP, Inc. for marketing its new Blood Pressure Insights (BPI) feature without federal authorization. While WHOOP claims the BPI provides daily systolic and diastolic estimations to help members understand their wellness better, the FDA sees it differently. According to the agency, BPI crosses the line from “wellness tech” into the world of regulated medical devices—and that’s a serious matter.
Why It Matters
If you’re wearing a WHOOP band expecting reliable blood pressure estimates, here’s the catch: BPI hasn’t gone through FDA review to ensure its accuracy or safety. This matters a lot because blood pressure isn’t something to guess at—especially if you’re managing hypertension or cardiovascular risks. The FDA is essentially saying, “Nice idea, but show us the science first.”
WHOOP’s Legal Stand—and FDA’s Pushback
WHOOP’s team argued that BPI is just a wellness feature—not a diagnostic tool—and shouldn’t be classified as a medical device. But the FDA strongly disagrees. Since BPI delivers a blood pressure number, color-coded ranges, and even claims to affect performance, recovery, and sleep, it automatically falls into regulated territory. And just slapping on disclaimers doesn’t change that.
What’s at Risk?
The FDA made it crystal clear: BPI is being marketed illegally. WHOOP now risks regulatory action including seizures, fines, injunctions, and possibly getting blocked from federal contracts. This could impact WHOOP’s reputation, partnerships, and its ability to introduce future health-related features.
What Should You Do?
- Use Caution: If you’re using WHOOP to track blood pressure, don’t rely on BPI for medical decisions. For now, it’s unverified.
- Stay Informed: Expect updates as WHOOP responds to the FDA. This may include changes to the feature, removal from the app, or a push for official clearance.
- Your Health Matters: Blood pressure tools must be clinically validated. When in doubt, trust FDA-cleared devices or consult a physician.
The Bigger Picture: Health Wearables Are Growing Up
This moment is a wake-up call for the entire wearables industry. As brands blur the lines between fitness and health diagnostics, the FDA is stepping in to enforce what’s fact vs. feature. And for consumers like us? That means more accountability, more transparency, and—hopefully—better products.
TL;DR, Geeks
WHOOP’s Blood Pressure Insights feature has been flagged by the FDA for skipping the regulatory approval process. It’s not just a slap on the wrist—this could impact how wearables roll out future health-tracking features. Stay smart, and don’t confuse fitness tech with medical-grade tools… until they earn the badge.
Source: USFDA 07.15.25
Visit geekofchic.com for more wearable tech news, reviews, and insight.